Changes in the Board of Directors at Karolinska Development
(Thomson Reuters ONE) -
STOCKHOLM - October 31, 2017. Karolinska Development today announces that Dr Ewa
Björling will be proposed for inclusion in the company's Board of Directors,
following the resignation of Board director Hans-Olov Olsson.
Dr Ewa Björling is a qualified dentist as well as a Medical Doctor and lecturer
in virology. She is a former member of the Swedish parliament and served as
Sweden's Minister for Trade between 2007- 2014 and for a shorter period also as
Minister for Nordic Cooperation. Moreover, she has been employed at the
Department of Microbiology, Tumor and Cell Biology (MTC) at Karolinska
Institutet in Solna. Ewa Björling has previous engagements as a Board member of
Essity AB, BioGaia AB and Mobilaris AB among others.
Hans-Olov Olsson has chosen to resign from the Board of Directors at his own
request. He joined the Board in 2017.
According to the Article of Association, the Board of Directors of Karolinska
Development should contain at least three and no more than nine members, and
alternates shall not be appointed. Following the resignation of Hans-Olov
Olsson, the Board consists of six members. The company intends to convene an
Extra General Meeting to decide on the Nomination Committees proposal for the
election of Ewa Björling.
For further information, please contact:
Niclas Adler, Chairman of the Board and member of the Nomination Committee,
Karolinska Development AB
Phone: +46 76 168 07 50, e-mail: niclas.adler(at)karolinskadevelopment.com
Ulf Richenberg, General Counsel, Karolinska Development AB
Phone: +46 70 29 860 25, e-mail: ulf.richenberg(at)karolinskadevelopment.com
TO THE EDITORS
About Karolinska Development AB
Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences
investment company. The company focuses on identifying breakthrough medical
innovations in the Nordic region that are developed by entrepreneurs and
leadership teams. The Company invests in the creation and growth of companies
that advance these assets into commercial products that are designed to make a
difference to patients' lives while providing an attractive return on investment
to shareholders.
Karolinska Development has access to world-class medical innovations at the
Karolinska Institutet and other leading universities and research institutes in
the Nordic region. The Company aims to build companies around scientists who are
leaders in their fields, supported by experienced management teams and advisers,
and co-funded by specialist international investors, to provide the greatest
chance of success.
Karolinska Development has established a portfolio of nine companies targeting
opportunities in innovative treatment for life-threatening or serious
debilitating diseases.
The Company is led by an entrepreneurial team of investment professionals with a
proven track record as company builders and with access to a strong global
network.
For more information, please visit www.karolinskadevelopment.com
This information is information that Karolinska Development AB (publ) (Nasdaq
Stockholm: KDEV) is obliged to make public pursuant to the EU Market Abuse
Regulation. The information was submitted for publication, through the agency of
Viktor Drvota, at 08:00 CET on 31(th) of October 2017.
PR KD Board Change_Final:
http://hugin.info/143071/R/2145826/822684.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Karolinska Development AB (publ) via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 31.10.2017 - 08:00 Uhr
Sprache: Deutsch
News-ID 565939
Anzahl Zeichen: 4137
contact information:
Town:
Solna
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 215 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Changes in the Board of Directors at Karolinska Development"
steht unter der journalistisch-redaktionellen Verantwortung von
Karolinska Development AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
